MariMed (OTCMKTS:MRMD – Get Free Report) is expected to release its earnings data after the market closes on Wednesday, March 5th. Analysts expect MariMed to post earnings of ($0.01) per share and revenue of $42.00 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
MariMed Price Performance
OTCMKTS MRMD opened at $0.12 on Wednesday. The stock has a market capitalization of $45.47 million, a price-to-earnings ratio of -2.98 and a beta of 2.81. MariMed has a 1-year low of $0.11 and a 1-year high of $0.34. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.55 and a quick ratio of 0.73. The business’s fifty day moving average price is $0.12 and its 200-day moving average price is $0.15.
MariMed Company Profile
Featured Articles
- Five stocks we like better than MariMed
- Retail Stocks Investing, Explained
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- What is the Euro STOXX 50 Index?
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.